- Home
- GPCR vs PARR Comparison
GPCR vs PARR Comparison
Compare GPCR & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- PARR
- Stock Information
- Founded
- GPCR 2016
- PARR 1984
- Country
- GPCR United States
- PARR United States
- Employees
- GPCR N/A
- PARR N/A
- Industry
- GPCR
- PARR Integrated oil Companies
- Sector
- GPCR
- PARR Energy
- Exchange
- GPCR Nasdaq
- PARR Nasdaq
- Market Cap
- GPCR 1.2B
- PARR 1.5B
- IPO Year
- GPCR 2023
- PARR N/A
- Fundamental
- Price
- GPCR $30.52
- PARR $35.50
- Analyst Decision
- GPCR Strong Buy
- PARR Hold
- Analyst Count
- GPCR 8
- PARR 5
- Target Price
- GPCR $69.57
- PARR $32.00
- AVG Volume (30 Days)
- GPCR 1.0M
- PARR 1.4M
- Earning Date
- GPCR 11-12-2025
- PARR 11-03-2025
- Dividend Yield
- GPCR N/A
- PARR N/A
- EPS Growth
- GPCR N/A
- PARR N/A
- EPS
- GPCR N/A
- PARR N/A
- Revenue
- GPCR N/A
- PARR $7,614,628,000.00
- Revenue This Year
- GPCR N/A
- PARR N/A
- Revenue Next Year
- GPCR N/A
- PARR N/A
- P/E Ratio
- GPCR N/A
- PARR N/A
- Revenue Growth
- GPCR N/A
- PARR N/A
- 52 Week Low
- GPCR $13.22
- PARR $11.86
- 52 Week High
- GPCR $42.57
- PARR $38.60
- Technical
- Relative Strength Index (RSI)
- GPCR 72.59
- PARR 52.78
- Support Level
- GPCR $25.67
- PARR $33.98
- Resistance Level
- GPCR $30.93
- PARR $37.38
- Average True Range (ATR)
- GPCR 1.81
- PARR 1.72
- MACD
- GPCR 0.33
- PARR -0.29
- Stochastic Oscillator
- GPCR 94.40
- PARR 43.70
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.